Mir-144 Selectively Regulates Embryonic Alpha-Hemoglobin Synthesis During Primitive Erythropoiesis

Yan-Fang Fu,Ting-Ting Du,Mei Dong,Kang-Yong Zhu,Chang-Bin Jing,Yong Zhang,Lei Wang,Hong-Bo Fan,Yi Chen,Yi Jin,Gui-Ping Yue,Sai-Juan Chen,Zhu Chen,Qiu-Hua Huang,Qing Jing,Min Deng,Ting Xi Liu
DOI: https://doi.org/10.1182/blood-2008-08-174854
IF: 20.3
2009-01-01
Blood
Abstract:Precise transcriptional control of developmental stage-specific expression and switching of alpha- and beta-globin genes is significantly important to understand the general principles controlling gene expression and the pathogenesis of thalassemia. Although transcription factors regulating beta-globin genes have been identified, little is known about the microRNAs and trans-acting mechanism controlling alpha-globin genes transcription. Here, we show that an erythroid lineage-specific microRNA gene, miR-144, expressed at specific developmental stages during zebrafish embryogenesis, negatively regulates the embryonic alpha-globin, but not embryonic beta-globin, gene expression, through physiologically targeting klfd, an erythroid-specific Kruppel-like transcription factor. Klfd selectively binds to the CACCC boxes in the promoters of both alpha-globin and miR-144 genes to activate their transcriptions, thus forming a negative feedback circuitry to fine-tune the expression of embryonic alpha-globin gene. The selective effect of the miR-144-Klfd pathway on globin gene regulation may thereby constitute a novel therapeutic target for improving the clinical outcome of patients with thalassemia. (Blood. 2009; 113: 1340-1349)
What problem does this paper attempt to address?